▲ Peaking
Business
Deramiocel heart-derived cellular therapy in advanced Duchenne muscular dystrophy (HOPE-3): a phase 3, randomised, double-blind, placebo-controlled trial
5 news sources are covering this Business story right now — Newsylist is tracking how fast it spreads.